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origin
Clin Microbiol Infect 1997; 3: 267-268
Borreliosis includes within its definition both relapsing
fever and Lyme disease. Relapsing fever has been
recognized in our province since at least the 1930s [1]
and is thought to be caused by Borrelia hermsii, which
is transmitted by the soft tick Ornithodoros hermsii.
Anecdotes of relapsing fever are reported on an almost
yearly basis in British Columbia and Alberta, although
few of these cases are published [2], and one of the
largest recognized outbreaks of tick-borne relapsing
fever in North America was recognized in the Browne
Mountain area of Washington state, in close proximity
to the British Columbia-Washington border [3]. In
addition, Lyme disease has been recognized among
British Columbians, although travel to other endemic
areas is a feature in the history of most patients.
Whereas the clinical manifestations of Lyme disease are
now well detailed for both children and adults [4,5], a
relapsing fever pattern or prolonged fever of unknown
origin have not been published in the pediatric medical
literature. We here describe an illness consisting of
prolonged fever of unknown origin which developed
in a child who acquired an endemic Borrelia burgdoiferi
infection in British Columbia.
A 13-month-old-female from central British
Columbia developed a right forearm rash 2 weeks after
an expedition to a lake in central British Columbia in
late June. The parents recalled an 'insect bite' at the site
of the dermatopathy, although a specific insect could
not be defined. The rash was described as having a pale
center and a red expanding circular edge. Coincident
with the disappearance of the rash after 3-4 weeks,
a fever developed and was measured maximally at
approximately 40°C orally. The child received oral
amoxycillin during the time when the fever persisted
but appeared to have a moderate anaphylactoid reaction
consisting of rash and listlessness. Although an anti-
biotic allergy was considered, the child had received
oral amoxycillin on one occasion previously without
side effects. The patient subsequently received oral co-
trimoxazole and the febrile illness resolved over 2
weeks. On a weekly basis thereafter, however, and
for the 6 subsequent months, the fever recurred,
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lasting for 1-3 days and reaching 38-39°C orally.
The febrile episodes were commonly accompanied by
nausea and transient diarrhea. During this interval, the
patient received several antibiotic courses, including
cotrimoxazole and cefaclor for presumed urinary tract
and middle ear infections. Antibiotic use, however, did
not seem to affect the subsequent reappearance of the
febrile illness. Although the forearm rash had com-
pletely disappeared without local residua, both legs and
arms developed areas of eczematoid rash.
Laboratory data during the weekly illnesses were
generally not helpful in providing a diagnosis, although
two immunofluorescence antibody (IFA) titers to B.
burgdoiferi were both recorded as 11256, at 2 and 3
months after the onset ofillness. The family history was
considerably complicated by the diagnosis of an in-
herited mitochondrial disorder in the father (including
cardiomyopathy) and two siblings. Furthermore, the
mother had recurrent urinary tract infection and the
father required a right nephrectomy because of a
complicated ureteral obstruction. There was no history
of travel outside British Columbia.
The child was admitted to our children's hospital 6
months after the onset for investigation of the fever
recurrences and an apparent failure to thrive in the
context of the familial history of metabolic disease. A
change in weight from 50th percentile (birth) to 5th
percentile was observed. The child was afebrile at the
time of admission and the last febrile episode had
ceased 2 days before. Physical examination could not
determine a focus for infection. There was no evidence
of joint, central nervous system or cardiac disease.
Laboratory investigations revealed: white blood cell
(WBC) 10.0 x 109 /L (60% lymphocytes), hemoglobin
112 giL, and platelets 300 x 109 /L. Serum electrolytes,
creatinine, lactate, liver and muscle enzyme profiles
and amino acids were within the normal range. Both
electrocardiogram and echocardiogram were normal. A
repeat of the B. burgdoiferi serology once again revealed
an IFA titer of 11256. An IFA titer to B. hermsii was less
than 1/128. Western blot serology using B. burgdoiferi
antigen demonstrated immune recognition of seven
polypeptides in addition to the flagellar (41 kDa),
OspA and OspB antigens.
Fever was not recorded during 5 days in hospital
but returned 7 days later and again recurred on a
weekly basis. Oral erythromycin was administered
by the seventh month and continued for 10 days.
The child was afebrile during the antibiotic course
and has remained so after cessation of the same,
apart from a single episode of fever associated with
a urinary tract infection. The eczematoid rash dis-
appeared after the erythromycin treatment and has not
recurred.
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We believe that this child's illness was caused
by infection with B. burgdoiferi, or a very similar
bacterium, on the basis of the history of the erythema
chronicum migrans-like lesion following an insect bite
which preceded the recurrent febrile illness and the
serologic profIle [6]. The pattern of fever, although
recurrent, did not typify the usual descriptions of
relapsing fever [7]. Rather, this illness would have
been more accurately classifIed as a 'fever of unknown
origin'. The response to erythromycin is also consistent
with borreliosis. Furthermore, we postulate that the
amoxycillin-associated anaphylaxis and the eczematoid
rash were probably a Jarisch-Herxheimer reaction and
a chronic Borrelia dermatopathy respectively.
Fever is a relatively common symptom in pediatric
Lyme disease. Williams et al. [5] found fever (> 101°F)
to be present in approximately one-half of all patients.
In addition, the latter investigators found that the
common clinical characteristics included erythema
chronicum migrans-like rash, 'flu-like' symptoms, arth-
ritis/arthralgia, and a history of tick bite. A prolonged
and recurrent febrile illness, as witnessed for our
patient, has not been described among children. Inter-
mittent and recurrent fever is, however, a hallmark of
the relapsing fever illnesses that are caused by non-B.
burgdoiferi borreliae, but the frequency of such recur-
rences is generally 1-5; again very unlike our patient
[7]. The Borrelia serology for our patient was not
supportive of B. hermsii infection.
Fever of unknown origin has long been studied,
especially in adults, and the need for a defInition which
is based on length of undiagnosed illness has been
proposed. The addition of Lyme disease to the list
of etiologic agents possibly associated with fever of
unknown origin would only have been possible over
the last decade, when the causative bacterium was
discovered and when the laboratory diagnosis could be
more certain. Indeed, Kazanjian [8] attributed fever of
unknown origin to Lyme disease in 1 of 86 patients in
a contemporary series. Nevertheless, the clinical course
of our patient was unusual, given the especially pro-
longed course ofthe febrile illness. It is conceivable that
similar presentations may become more numerous as
experience with pediatric Lyme disease increases.
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Disseminated mucormycosis due to Absidia corymbifera in
a patient with inflammatory bowel disease
Clin Microbiol Infect 1997; 3: 268-270
Mucormycosis is a rare fungal disease principally caused
by species of the order Mucorales, family Mucoraceae
(Rhizopus, Rhizomucor, Absidia and Mucor) [1]. This
infection is usually seen in patients with certain
underlying diseases and predisposing conditions. One
of the most important features of the disease is that
diagnosis is rare ante mortem, since signs and symptoms
are non-specifIc, and the clinical course is often
fatal, especially in disseminated forms. However, the
infection is potentially curable with systemic admini-
stration of amphotericin B, agressive surgical debride-
ment, and control of the underlying disease. We report
a disseminated form ofmucormycosis caused by Absidia
corymbifera, in a patient under treatment with steroids
and cytostatic agents because of inflammatory bowel
disease.
A 60-year-old man was admitted to the hospital
on 12 January 1995, following a 14-day history of
